Press Room

Press Releases

View Archive: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

November 25, 2008 – Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma

July 15, 2008 – Light Sciences Oncology Raises $40.1 Million in Series C Financing

July 7, 2008 – Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate

April 7, 2008 – Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors